TORSKAL is an international biotechnology company, a pioneer of green nanotechnology. We design disruptive gold nanoparticles for cancer therapy from green chemistry.
We are committed to the development of a new generation of non-toxic and eco-friendly nanomaterials for the treatment of surface and deep cancers by green chemistry. We have discovered an innovative, green, and patented way of producing gold nanoparticles, leveraging Indian Ocean endemic plants, that have many applications in health.
Our first and main project, the Nanotheranostics Project (NT1), a treatment for skin cancer using near-infrared (IR) radiation-induced plasmonic phototherapy is entering phase 1 of clinical trials by the end of 2021.
This will be followed by our second project, Deep Cancer (NT2), which aims to develop new nanotheranostics for the treatment of deep cancers such as prostate and pancreatic cancers is currently in the drug phase.
We also sell our unique gold nanoparticles through our websites e-commerce platform which has a wide range of applications in diagnostics, research, industry, and others.
TORSKAL is currently located in Europe (France, La Réunion), China, and the US.
